U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
5085150851Imaging Biomarkers for TMS Treatment of DepressionRecruitingNo Results AvailableDepressionDevice: repetitive Transcranial Magnetic Stimulation (rTMS)https://ClinicalTrials.gov/show/NCT01900314
5085250852Generalization of Extinction LearningRecruitingNo Results AvailableSocial Anxiety DisorderDrug: Scopolamine|Drug: intranasal placebohttps://ClinicalTrials.gov/show/NCT01900301
5085350853Home Parenteral Nutrition (HPN) Families' Mobile Distance Connections to Care ResearchActive, not recruitingNo Results AvailableShort Bowel Syndrome|Malabsorption|MalnutritionBehavioral: HPN Group Clinic Appointments using Mobile Devices (experimental)|Behavioral: Mobile Device Access (placebo)https://ClinicalTrials.gov/show/NCT01900288
5085450854Urinary Heparanase Activity as a Predictor of Acute Kidney Injury in Critically Ill AdultsCompletedNo Results AvailableSepsis|Trauma|Shock|Acute Kidney InjuryOther: Urine collectionhttps://ClinicalTrials.gov/show/NCT01900275
5085550855Exercise Interventions, Running Biomechanics and Injury in Novice RunnersActive, not recruitingNo Results AvailableRunning|Leg InjuriesOther: Strengthening|Other: Balance Training|Other: Stretchinghttps://ClinicalTrials.gov/show/NCT01900262
5085650856To Assess the Safety and Efficacy of R932348 Ophthalmic Solutions in Patients With Keratoconjunctivitis SiccaCompletedNo Results AvailableKeratoconjunctivitis SiccaDrug: R348 Ophthalmic Solution, 0.2%|Drug: R348 Ophthalmic Solution, 0.5%|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01900249
5085750857Integrating ENGagement and Adherence Goals Upon Entry iENGAGE to Control HIVRecruitingNo Results AvailableHIVBehavioral: Based on behavioral motivational interviewing (MI) techniquehttps://ClinicalTrials.gov/show/NCT01900236
5085850858Chronic Pain After Shoulder ArthroplastyCompletedNo Results AvailableChronic Painhttps://ClinicalTrials.gov/show/NCT01900223
5085950859Sustainable HIV Risk Reduction Strategies for CJ SystemsCompletedNo Results AvailableHIV Risk BehaviorsBehavioral: WaySafehttps://ClinicalTrials.gov/show/NCT01900210
5086050860Time to Relapse of Iron Deficiency Anemia After Standard Treatment With a New Intravenous Iron (Monofer®)Active, not recruitingNo Results AvailableIron Deficiency AnemiaDrug: 10% Iron Isomaltoside 1000https://ClinicalTrials.gov/show/NCT01900197
5086150861Study of the Product QGC001 as a Single Dose and Multiple Doses Administered Orally to Healthy Adult SubjectsCompletedNo Results AvailableEssential HypertensionDrug: QGC001 [(3S,3'S)-4,4'-dithiobis (3-aminobutane-1-sulfonic acid)]|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01900184
5086250862Phase I Study in Healthy Male Subjects Comparing QGC001 to PlaceboCompletedNo Results AvailableEssential HypertensionDrug: QGC001 [(3S,3'S)-4,4'-dithiobis (3-aminobutane-1-sulfonic acid)]|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01900171
5086350863A Phase I/II Study Safety and Efficacy Study of PCI of Gemcitabine and Chemotherapy in Patients With CholangiocarcinomasRecruitingNo Results AvailableCholangiocarcinomaDrug: Amphinex and Gemcitabine|Drug: Gemcitabine and Cisplatinhttps://ClinicalTrials.gov/show/NCT01900158
5086450864Electrical Impedance Myography: Exploratory Studies in Healthy People and People With Neuromuscular DisordersRecruitingNo Results AvailableNeuromuscular Disease|Motor Neuron Disease|Inherited Neuromuscular Conditions|Inherited Neuropathieshttps://ClinicalTrials.gov/show/NCT01900132
5086550865A Description of Bacteria in the Mouths of Patients With Severe Aplastic AnemiaRecruitingNo Results AvailableSevere Aplastic Anemia (SAA)https://ClinicalTrials.gov/show/NCT01900119
5086650866A Prospective, Open-label Trial of Two Abacavir/Lamivudine Based Regimen (ABC/3TC + Darunavir/Ritonavir or ABC/3TC + Raltegravir) in Late Presenter naïve Patients (With CD4 Count - Not yet recruitingNo Results AvailableHIV InfectionDrug: abacavir/lamivudine + raltegravir|Drug: abacavir/lamivudine + darunavir/ritonavirhttps://ClinicalTrials.gov/show/NCT01900106
5086750867Evaluation of the Response to Acthar Gel Therapy in Patients Who Failed Intravenous Methylprednisolone (IVMP) for MS RelapsesRecruitingNo Results AvailableMultiple SclerosisDrug: Acthar Gelhttps://ClinicalTrials.gov/show/NCT01900093
5086850868Same-Day HIV Testing and Treatment Initiation to Improve Retention in CareRecruitingNo Results AvailableHIVOther: Same-Day HIV testing and ART initiation|Other: Standard ART Initiation|Other: Sub-Study: Same-Day ART, CD4 Count >500|Other: Sub-Study: Standard Pre-ART Care, CD4 Count >500https://ClinicalTrials.gov/show/NCT01900080
5086950869Study to Evaluate Safety and Efficacy of Blanket Used to Prevent Anesthesia Induced HypothermiaCompletedHas ResultsAnesthesia Induced Hypothermia|Inadvertent Perioperative HypothermiaDevice: BARRIER® EasyWarm Active Self-Warming Blankethttps://ClinicalTrials.gov/show/NCT01900067
5087050870A Long-Term Study of TAU-284 in Pediatric Patients With Perennial Allergic RhinitisCompletedNo Results AvailablePerennial Allergic RhinitisDrug: Bepotastine besilatehttps://ClinicalTrials.gov/show/NCT01900054
5087150871A Study to Evaluate the Superiority, Efficacy and Tolerability of Combination Pantovigar With 2% Minoxidil vs 2% Minoxidil in Women With Female Pattern Hair LossCompletedNo Results AvailableFemale Pattern Hair Loss|Androgenetic Alopecia (AGA)|Ludwig Type 1|Ludwig Type 2Drug: Pantovigar|Drug: Minoxidil 2% onlyhttps://ClinicalTrials.gov/show/NCT01900041
5087250872To Assess the Effect of Itraconazole (a CYP3A4 Inhibitor) on the Pharmacokinetics of Olaparib, and the Effect of Olaparib on QT Interval Following Oral Dosing of a Tablet Formulation to Patients With Advanced Solid TumoursActive, not recruitingNo Results AvailableSolid TumoursProcedure: Pharmacokinetic sampling|Drug: Olaparib tablet dosing|Drug: Itraconazolehttps://ClinicalTrials.gov/show/NCT01900028
5087350873CHANGES IN LIVER STEATOSIS AFTER SWITCHING TO RALTEGRAVIR IN HIV/HCV COINFECTIONNot yet recruitingNo Results AvailableHCV Coinfection|HIV InfectionDrug: Raltegravir|Drug: Efavirenzhttps://ClinicalTrials.gov/show/NCT01900015
5087450874Sorafenib and Yttrium-90 Glass Microspheres for Advanced Hepatocellular Carcinoma (HCC)RecruitingNo Results AvailableLiver CancerDrug: Sorafenib|Radiation: Yttrium-90 Microspheres|Behavioral: Follow-Up Phone Callshttps://ClinicalTrials.gov/show/NCT01900002
5087550875Stereotactic Body Radiation Therapy for Inoperable Locally-advanced Non-small Cell Lung CancerRecruitingNo Results AvailableNon-small Cell Lung CancerRadiation: Stereotactic Body Radiation Therapy (SBRT)|Drug: cisplatin or carboplatin-basedhttps://ClinicalTrials.gov/show/NCT01899989
5087650876X-MAS Biliary Study With Covered Biliary StentRecruitingNo Results AvailableMalignant Strictures in the Biliary TreeDevice: X-Suit NIR Covered Biliary Stenthttps://ClinicalTrials.gov/show/NCT01899976
5087750877Time to Treatment Utilizing a Tele-Retinal Referral System for Wet Age Related Macular Degeneration and Diabetic Macular Edema: A Pilot StudyRecruitingNo Results AvailableWet Age Related Macular Degeneration|Diabetic Macular Edemahttps://ClinicalTrials.gov/show/NCT01899963
5087850878Longitudinal Study of Cognition With Niemann-Pick Disease, Type CCompletedNo Results AvailableNiemann-Pick Disease, Type Chttps://ClinicalTrials.gov/show/NCT01899950
5087950879Effect of Different Methodologies on Variability of Brachial Artery Flow Mediated DilationActive, not recruitingNo Results AvailableEndothelial Dysfunctionhttps://ClinicalTrials.gov/show/NCT01899937
5088050880Cognitive Assessment by the Mean of Event Related PotentialsRecruitingNo Results AvailableBrain InjuriesBehavioral: Event Related Potentials recordinghttps://ClinicalTrials.gov/show/NCT01899924

* Görseller ve İçerik tekif hakkına sahip olabilir